Human chorionic gonadotropin­ beta in endometrium cancer tissue

Purpose: Determination of the correlation between expression of human chorionic gonadotropin mRNA and serum free hCGb immunoreactivity in endometrial cancer tissue.

Methods: The study included 56 patients with endometrial carcinoma Stages IB-III. The expression of mRNA hCGbeta was determined by the RT PCR method in 18 cases of cancerous and precancerous tissues. The serum-free hCGbeta immunoreactivity was analyzed by sequential immunometric assay in all patients.

Results: In 15 study specimens of endometrial carcinoma tissue mRNA of hCGbeta was detected. Also in endometrial atypical hyperplasia, expression of hCGbeta was found. Noncancerous tissue demonstrated lack of the hCGbeta transcript. The serum immunoreactivity in the endometrial cancer group was detectable in 86% of cases. There were no significant differences between FIGO stages and grading.

Conclusion: The results of the present study confirmed the presence of active genes of hCGbeta in endometrial cancer tissue, even in precancerous changes. The serum immunoreactivity of free hCGbeta is a less common feature and is not linked with tumor stage or grade in endometrial cancer patients.

Human chorionic gonadotropin beta; mRNA of hCG/3;Endometrial carcinoma

[1] Pierce J.G., Parson T.F.: "Glycoprotein hormones: structure and function". Ann. Rev. Biochem., 1981, 50, 465.

[2] Bagshawe K.D.: "Choriocarcinoma. A model of tumor markers". Acta Oneal., 1992, 31, 99.

[3] Ozturk M.: "Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease". J. Reprod. Med., 1991, 36, 21.

[4] McLoughlin J., P epera T., Bridger J., Williams G.: "Serum and urinary levels of beta chorionic gonadotropin in patients with transitional cell carcinoma". Br. J. Cancer, 1991, 63, 822.

[5] Grossman M., Trautmann M.E., P oertl S., Hoermann R., Berger P., Arnold R., Mann K.: "Alfa-subunit and human chorionic gonadotropin - p immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumors". Eur. J. Clin. Invest., 1994, 24, 131.

[6] Szturmowicz M., Wiatr E., Sakowicz A., Slodkowska J., Roszkowski K., Filipecki S., Rowinska-Zakrzewska E.: "The role of human chorionic gonadotropin P-subunit elevation in small-cell lung cancer patients". Can. Res. Clin. Oneal., 1995, 121, 309.

[7] Grossmann M., Hoermann R., Gocze P.M., Ott M., Berger P., Mann K.: "Measurement of human chorionic gonadotropin-related immunoreactivity in serum, ascites and tumor cysts of patients with gynecologic malignancies". Eur. J. Clin. Invest., 1995, 25, 867.

[8] Carpelan-Holmstrom M., Haglund C., Lundin J., Alfthan H., Stenman U.-H., Roberts P.J.: "Independent prognostic value of preoperative serum markers CA-125, specific tissue polypeptide antigen and human chorionic gonadotropin beta, but not carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer". Br. J. Cancer, 1996, 74, 925.

[9] Webb A., Scott-Mackie P., Cunningham D., Norman A., Andreyev J., O'Brien M., Bensted J.: "The prognostic value of serum and immunohistochemical tumor markers in advanced gastric cancer". Eur. J. Cancer, 1996, 32A, 63.

[10] Acevedo H.F., K门schevsky A., Campbell-Acevedo E.A., Galyon J.C., Buffo M.J., Hartsock R.J.: "Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells". Cancer, 1992, 69, 1818.

[11] Acevedo H.F., Krischevsky A., Campbell-Acevedo E.A., Galyon J.C., Buffo M.J., Hartsock R.J.: "Expression of membrane associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells". Cancer, 1992, 69, 1829.

[12] Cole L.A., Schwartz P.E., Wang Y.X.: "Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers". Gynecol. Oneal., 1988, 31, 82.

[13] Ind T., Iles R.K., Shepherd J., Chard T.: "Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotropin as prognostic markers for epithelial ovarian cancer". Br. J. Obstet. Gynecol., 1997, 104, 1024.

[14] Carter P.G., Iles R.K., Neven P.: "Measurement of urinary beta core fragment of human chorionic gonadotropin in women with vulvovaginal malignancy and it prognostic significance". Br. J. Cancer, 1995, 71, 350.

[15] Carter P.G., Iles R.K., Neven P.: "The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix". Gynecol. Oneal., 1994, 55, 271.

[16] Acevedo H.F., Hartsock R.J.: "Metastatic phenotype correlates with high expression of membrane-associated complete human chorionic gonadotropin in vivo". Cancer, 1996, 78, 2388.

[17] Laphom A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J. et al.: "Crystal structure of hCG". Nature, 1994, 369, 455.

[18] Wu H., Lustbader J.W., Liu Y., Canfield R.E., Hendrickson W.A.: "Structure of human chorionic gonadotropin at 2-6 A resolution from MAD analysis of the selenomethionyl protein". Structure, 1994, 2, 545.

[19] Murray-Rust J., McDonald N.Q., Blundell T.L., Hosang M., Oefner C.,W inkler F.,B radshaw R.A.: "Topological similarities in TGF-P2, P DGF-BB and NGF define a superfamily of polypeptide growth factors". Structure, 1993, 1, 153.

[20] Sun P.D., Davies D.R.: "The cystine-knot growth-factor superfamily". Ann. Rev. Biophys Biomolec. Struct., 1995, 24, 269.

[21] Rivera R.T., P asion S.G., Wong D.T.W., Fei Y., Biswas D.K.: "Loss of tumorigenic potential by human lung tumor cells in the presence of antisense RNA specific to the ectopically synthesized alpha subunit of human chorionic gonadotropin". J. Cell. Biol., 1989, 108, 2423.

[22] Contractor S.F., Davies H.: "Effect of human chorionic somatomammotropin and human chorionic gonadotropin on phytohaemagglutinin- induced lymphocyte transformation". Nat. New Biol., 1973, 243, 284.

[23] Fabris N., P iantanelli L., Muzzioli M.: "Different effect of pregnancy or gestagens on humoral and cell-mediated immunity". Clin. Exp. lmmunol., 1977, 28, 306.

[24] Strelkauskas A.J., Wilson B.S., Dray D., Dodson M.: "Inversion of levels of human T and B cells in early pregnancy". Nature, 1975, 258, 331.

[25] Gawronska B., Leuschner C., Enright F.M., Hansel W.: "Effects of a lytic P eptide conjugated to Beta HCG on ovarian cancer: Studies in vitro and in vivo". Gynecol. Oneal., 2002, 85, 45.